{"id":"https://openalex.org/W2790553333","doi":"https://doi.org/10.1093/toxsci/kfy048","title":"Nonclinical Safety Assessment of the \u03b3-Secretase Inhibitor Avagacestat","display_name":"Nonclinical Safety Assessment of the \u03b3-Secretase Inhibitor Avagacestat","publication_year":2018,"publication_date":"2018-02-23","ids":{"openalex":"https://openalex.org/W2790553333","doi":"https://doi.org/10.1093/toxsci/kfy048","mag":"2790553333","pmid":"https://pubmed.ncbi.nlm.nih.gov/29529279"},"language":"en","primary_location":{"id":"doi:10.1093/toxsci/kfy048","doi":"https://doi.org/10.1093/toxsci/kfy048","is_oa":false,"landing_page_url":"https://doi.org/10.1093/toxsci/kfy048","pdf_url":null,"source":{"id":"https://openalex.org/S186282544","display_name":"Toxicological Sciences","issn_l":"1096-0929","issn":["1096-0929","1096-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051372460","display_name":"Frank Simutis","orcid":"https://orcid.org/0000-0003-0211-9665","observed_orcids":["https://orcid.org/0000-0003-0211-9665"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Frank J Simutis","raw_affiliation_strings":["Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069300682","display_name":"Thomas P. Sanderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas P Sanderson","raw_affiliation_strings":["Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036288048","display_name":"Gary D. Pilcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary D Pilcher","raw_affiliation_strings":["Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036891049","display_name":"Michael J. Graziano","orcid":"https://orcid.org/0000-0002-8199-9842","observed_orcids":["https://orcid.org/0000-0002-8199-9842"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J Graziano","raw_affiliation_strings":["Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051372460"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":4671,"currency":"USD","value_usd":4671},"apc_paid":null,"fwci":0.8577,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.71911285,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"163","issue":"2","first_page":"525","last_page":"542"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gamma-secretase-inhibitors","display_name":"gamma-secretase inhibitors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.7870000004768372},{"id":"https://openalex.org/keywords/notch-signaling-inhibition","display_name":"Notch signaling inhibition","score":0.8399999737739563},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.8790000081062317},{"id":"https://openalex.org/keywords/lymphoid-depletion","display_name":"lymphoid depletion","score":0.8489999771118164},{"id":"https://openalex.org/keywords/bone-changes","display_name":"bone changes","score":0.7329999804496765},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8090000152587891},{"id":"https://openalex.org/keywords/hes1","display_name":"Hes1","score":0.6069999933242798},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.7630000114440918},{"id":"https://openalex.org/keywords/sulfonamides","display_name":"sulfonamides","score":0.5270000100135803},{"id":"https://openalex.org/keywords/repeated-dose-toxicity","display_name":"repeated-dose toxicity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6015059947967529},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.5168881416320801},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.4927347004413605},{"id":"https://openalex.org/C2781172350","wikidata":"https://www.wikidata.org/wiki/Q194520","display_name":"Atrophy","level":2,"score":0.4585438072681427},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45771709084510803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4463281035423279},{"id":"https://openalex.org/C2778057883","wikidata":"https://www.wikidata.org/wiki/Q92793969","display_name":"Follicular cell","level":3,"score":0.42160066962242126},{"id":"https://openalex.org/C161879069","wikidata":"https://www.wikidata.org/wiki/Q904082","display_name":"Notch signaling pathway","level":3,"score":0.41244766116142273},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3959372639656067},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38461101055145264},{"id":"https://openalex.org/C187785154","wikidata":"https://www.wikidata.org/wiki/Q5464664","display_name":"Follicular phase","level":2,"score":0.2897603511810303},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1444842517375946}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010069","descriptor_name":"Oxadiazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010069","descriptor_name":"Oxadiazoles","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018675","descriptor_name":"Toxicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D041981","descriptor_name":"Gastrointestinal Tract","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051880","descriptor_name":"Receptors, Notch","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/toxsci/kfy048","doi":"https://doi.org/10.1093/toxsci/kfy048","is_oa":false,"landing_page_url":"https://doi.org/10.1093/toxsci/kfy048","pdf_url":null,"source":{"id":"https://openalex.org/S186282544","display_name":"Toxicological Sciences","issn_l":"1096-0929","issn":["1096-0929","1096-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological Sciences","raw_type":"journal-article"},{"id":"pmid:29529279","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29529279","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological sciences : an official journal of the Society of Toxicology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7400000095367432,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":85,"referenced_works":["https://openalex.org/W40611030","https://openalex.org/W69139415","https://openalex.org/W188237391","https://openalex.org/W1485233386","https://openalex.org/W1522868374","https://openalex.org/W1568038787","https://openalex.org/W1568731054","https://openalex.org/W1616122655","https://openalex.org/W1893910909","https://openalex.org/W1928655587","https://openalex.org/W1970905438","https://openalex.org/W1971784499","https://openalex.org/W1974600364","https://openalex.org/W1980212327","https://openalex.org/W1980992536","https://openalex.org/W1985375469","https://openalex.org/W1990442683","https://openalex.org/W1992111088","https://openalex.org/W1993428183","https://openalex.org/W1997801717","https://openalex.org/W1999316583","https://openalex.org/W2002912960","https://openalex.org/W2008688231","https://openalex.org/W2009951097","https://openalex.org/W2016193774","https://openalex.org/W2019437260","https://openalex.org/W2019573723","https://openalex.org/W2025563134","https://openalex.org/W2030574301","https://openalex.org/W2033043320","https://openalex.org/W2035066075","https://openalex.org/W2038352605","https://openalex.org/W2041572974","https://openalex.org/W2042082068","https://openalex.org/W2042163600","https://openalex.org/W2044749425","https://openalex.org/W2045826462","https://openalex.org/W2049090800","https://openalex.org/W2065706231","https://openalex.org/W2067131315","https://openalex.org/W2072287846","https://openalex.org/W2078528430","https://openalex.org/W2080187876","https://openalex.org/W2081471404","https://openalex.org/W2083304655","https://openalex.org/W2083955521","https://openalex.org/W2084073639","https://openalex.org/W2085682228","https://openalex.org/W2087363756","https://openalex.org/W2097705657","https://openalex.org/W2098503611","https://openalex.org/W2105477022","https://openalex.org/W2112436745","https://openalex.org/W2112622667","https://openalex.org/W2114655589","https://openalex.org/W2115840354","https://openalex.org/W2116746992","https://openalex.org/W2120278489","https://openalex.org/W2124018740","https://openalex.org/W2126995971","https://openalex.org/W2127588983","https://openalex.org/W2129355202","https://openalex.org/W2130253814","https://openalex.org/W2133962760","https://openalex.org/W2135169290","https://openalex.org/W2142261382","https://openalex.org/W2144579631","https://openalex.org/W2154144191","https://openalex.org/W2154297075","https://openalex.org/W2154861644","https://openalex.org/W2156166049","https://openalex.org/W2158010257","https://openalex.org/W2158854213","https://openalex.org/W2163608364","https://openalex.org/W2164215375","https://openalex.org/W2167293538","https://openalex.org/W2169152986","https://openalex.org/W2291471126","https://openalex.org/W2326435909","https://openalex.org/W2418496451","https://openalex.org/W2517641217","https://openalex.org/W2925622520","https://openalex.org/W4247321555","https://openalex.org/W4253199270","https://openalex.org/W4409131105"],"related_works":["https://openalex.org/W2154297075","https://openalex.org/W2143024384","https://openalex.org/W1485233386","https://openalex.org/W2035000249","https://openalex.org/W2154556865","https://openalex.org/W2165519564","https://openalex.org/W2116961882","https://openalex.org/W1989654750","https://openalex.org/W1963588056","https://openalex.org/W188237391"],"abstract_inverted_index":{"The":[0],"toxicity":[1,33,226],"of":[2,44,50,59,81,100,119,172,182,188,195,227],"avagacestat,":[3],"a":[4,14,22,42,78,238,243],"sulfonamide-based":[5],"gamma":[6],"(\u03b3)-secretase":[7],"inhibitor":[8],"that":[9,27,53,115,242],"was":[10,19,41,247],"in":[11,21,35,64,133,143,149,161,166,204,212],"development":[12,62],"as":[13,152,154],"treatment":[15],"for":[16,224],"Alzheimer's":[17],"disease,":[18],"evaluated":[20],"comprehensive":[23],"nonclinical":[24],"toxicology":[25],"program":[26],"included":[28,131],"6-month":[29],"and":[30,37,57,63,70,75,77,85,106,108,140,146,157,168,177,179,193,233],"1-year":[31],"repeat-dose":[32],"studies":[34],"rats":[36,69],"dogs,":[38,71],"respectively.":[39],"There":[40],"spectrum":[43],"mechanism-based":[45],"changes":[46,160,236],"attributed":[47,125],"to":[48,113,126,210,220],"inhibition":[49],"Notch":[51,129],"signaling":[52,130],"regulates":[54],"the":[55,147,189,221,229],"differentiation":[56],"proliferation":[58],"cells":[60],"throughout":[61],"adult":[65],"tissues.":[66],"In":[67],"both":[68,150],"ovarian":[72],"follicular":[73],"degeneration":[74],"atrophy":[76],"low":[79],"incidence":[80],"granulosa":[82],"cell":[83,88,97,185],"hyperplasia":[84],"benign":[86],"granulosa-thecal":[87],"tumors":[89],"were":[90,111],"observed.":[91],"Gastrointestinal":[92],"(GI)":[93],"findings,":[94],"including":[95],"goblet":[96],"metaplasia,":[98],"dilatation":[99],"intestinal":[101],"crypts/glands,":[102],"mucosal":[103],"epithelial":[104],"necrosis":[105],"regeneration,":[107],"villous":[109],"atrophy,":[110],"limited":[112],"dogs":[114,213],"had":[116],"clinical":[117],"evidence":[118],"GI":[120,225,235],"toxicity.":[121,253],"Other":[122],"avagacestat-related":[123],"findings":[124],"interference":[127],"with":[128],"decreases":[132,165],"peripheral":[134],"lymphocytes":[135],"(T":[136],"and/or":[137],"B":[138],"cells)":[139],"lymphoid":[141],"depletion":[142],"lymph":[144],"nodes":[145],"spleen":[148],"species,":[151],"well":[153],"epiphyseal":[155],"cartilage":[156],"trabecular":[158],"bone":[159],"rats.":[162],"Pharmacologically":[163],"mediated":[164],"brain":[167,205],"cerebrospinal":[169],"fluid":[170],"levels":[171,187,208],"\u03b2-amyloid":[173],"(A\u03b2)":[174],"peptides":[175],"A\u03b240":[176],"A\u03b242":[178],"decreased":[180],"expression":[181],"white":[183],"blood":[184],"mRNA":[186],"Notch-regulated":[190],"gene":[191],"hairy":[192],"enhancer":[194],"split-1":[196],"confirmed":[197],"target":[198],"engagement":[199],"at":[200,217,237,249],"all":[201],"doses.":[202],"Reductions":[203],"A\u03b2":[206],"peptide":[207],"(22":[209],"34%)":[211],"after":[214],"1":[215],"year":[216],"exposures":[218,250],"up":[219],"no-observed-effect":[222],"level":[223],"1.1\u00d7":[228],"human":[230],"plasma":[231],"exposure,":[232],"reversible":[234],"3.2\u00d7":[239],"multiple,":[240],"indicated":[241],"sustained":[244],"pharmacodynamic":[245],"effect":[246],"attained":[248],"without":[251],"dose-limiting":[252]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-03-29T00:00:00"}